Hold-rated reports

932 tickers rated Hold
Ranks this page's recent reports by score.
Thermo Fisher Scientific Inc.
TMO·Healthcare
B ★★★Hold
Current$673.82
Target$721.24
Return+7.0%
Oct 25, 2026

Thermo Fisher Scientific combines durable laboratory switching costs, recurring consumables, and recovering biopharma demand with strong cash generation, but demanding valuation and acquisition-related leverage limit near-term upside.

Score
73
Reliance, Inc.
RS·Materials
B ★★★Hold
Current$415.62
Target$408.00
Return-1.8%
Oct 25, 2026

Reliance combines North America's leading metals distribution platform with disciplined shareholder returns and strong cyclical earnings recovery, but elevated valuation and weak cash conversion limit near-term upside.

Score
65
Ryder System, Inc.
R·Industrials
B ★★★Hold
Current$270.90
Target$289.00
Return+6.7%
Oct 25, 2026

Ryder's recurring logistics contracts and improving fleet economics support continued earnings growth, but elevated historical valuation multiples and cyclical equipment-financing risks limit the margin of safety.

Score
69
Philip Morris International Inc.
PM·Consumer Staples
B ★★★Hold
Current$199.47
Target$202.40
Return+1.5%
Oct 25, 2026

Philip Morris International combines exceptional tobacco cash flows with expanding smoke-free nicotine franchises, but its premium valuation, regulatory exposure, and rising U.S. investment costs constrain near-term upside.

Score
70
PG&E Corporation
PCG·Utilities
B ★★★Hold
Current$12.63
Target$16.20
Return+28.3%
Oct 25, 2026

PG&E offers a protected California utility franchise and discounted earnings valuation with potential recovery from regulated investment growth, but persistent negative free cash flow, elevated debt, and wildfire liabilities constrain the investment case.

Score
74
Old Republic International Corporation
ORI·Financials
B ★★★Hold
Current$38.91
Target$42.64
Return+9.6%
Oct 25, 2026

Old Republic offers durable specialty insurance cash generation, diversified title exposure, and dependable shareholder returns, but deteriorating underwriting margins and a premium to book value constrain near-term upside.

Score
66
NextEra Energy, Inc.
NEE·Utilities
B ★★★Hold
Current$82.10
Target$87.00
Return+6.0%
Oct 25, 2026

NextEra Energy combines a durable regulated utility franchise with long-term renewable and electricity-demand growth, but heavy capital spending, leverage and Dominion merger uncertainty constrain near-term shareholder returns.

Score
69
MaxLinear, Inc.
MXL·Technology
B ★★★Hold
Current$63.46
Target$70.40
Return+10.9%
Oct 25, 2026

MaxLinear is gaining traction in high-speed AI data-center connectivity with accelerating revenue and improving margins, but demanding valuation, concentrated competition, and weak cash conversion constrain risk-adjusted upside.

Score
67
Medpace Holdings, Inc.
MEDP·Healthcare
B ★★★Hold
Current$669.20
Target$630.00
Return-5.9%
Oct 25, 2026

Medpace combines specialized clinical research expertise, high profitability, and strong cash generation with long-term outsourcing demand, but premium valuation and biotechnology funding sensitivity limit its near-term margin of safety.

Score
70
Southwest Airlines Co.
LUV·Industrials
B ★★★Hold
Current$41.75
Target$46.80
Return+12.1%
Oct 25, 2026

Southwest Airlines' commercial transformation and recovering earnings offer upside through better unit revenue and capital efficiency, but persistent negative free cash flow and airline cost volatility constrain the investment case.

Score
72
Hilltop Holdings Inc.
HTH·Financials
B ★★★Hold
Current$36.36
Target$38.84
Return+6.8%
Oct 25, 2026

Hilltop's strong capital, disciplined buybacks, and established Texas banking franchise support long-term value, but weak consolidated ROE and persistent mortgage losses constrain its upside potential.

Score
66
Hasbro, Inc.
HAS·Consumer Discretionary
B ★★★Hold
Current$117.44
Target$115.77
Return-1.4%
Oct 25, 2026

Hasbro's high-margin Magic franchise and licensing expansion support stronger cash generation and long-term returns, but elevated historical valuation and franchise concentration constrain the near-term upside.

Score
67